Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Texas: The Ultimate Resource for Patients and Families
For many women in Texas, the journey toward breast reconstruction or aesthetic improvement begins with a commitment to health and self-confidence. Whether you were navigating a post-mastectomy reconstruction at the Texas Medical Center in Houston, seeking a prophylactic procedure at a specialist center in Austin, or undergoing a cosmetic revision in Beaumont, you trusted that the medical devices placed in your body were proven safe. However, a growing body of clinical evidence and federal regulatory actions reveals that several products—specifically surgical meshes, acellular dermal matrices (ADMs), and bioabsorbable scaffolds—were never actually cleared by the FDA for breast surgery.
At The Manginello Law Firm, PLLC, operating under the consumer brand Attorney911, we recognize that you may be reading this while facing a catastrophic diagnosis like BIA-ALCL, a persistent infection, or the devastating loss of a reconstruction. Managing Partner Ralph Manginello, a Houston native with twenty-seven years of continuous practice (Texas Bar Card Number 24007597), and Associate Attorney Lupe Peña, a third-generation Texan with fluent Spanish capability, understand the unique medical and legal landscape patients face in Texas. We utilize our deep command of federal device regulations and state product liability law to fight for those injured by these defective devices. If you have questions about your health and your rights, contact us at 1-888-ATTY-911 for a confidential, no-obligation consultation.
Understanding the Devices: Mesh, ADM, and Scaffolds in Texas Breast Procedures
The “internal bra” technique has become a staple of modern breast surgery across Texas, from high-volume aesthetic practices in the Galleria area of Houston to academic surgical suites in Austin. Surgeons often use reinforcement materials to support the lower pole of the breast or to provide coverage for an implant. These materials generally fall into three categories:
- Acellular Dermal Matrix (ADM): These are biological “sheets” derived from human cadaver skin (allografts) or animal tissue (xenografts, such as porcine or bovine). Products like AlloDerm, Strattice, and FlexHD are processed to remove cells while leaving a structural collagen matrix that is meant to integrate with your own tissue.
- Bioabsorbable Scaffolds: These are synthetic constructs, such as GalaFLEX or Phasix, made from polymers like poly-4-hydroxybutyrate (P4HB). They are designed to provide temporary support and then slowly dissolve (resorb) as your body builds its own internal scar tissue.
- Synthetic Surgical Mesh: These are permanent or semi-permanent plastic meshes, often made of polypropylene, originally developed for hernia repair but used “off-label” by some surgeons to provide internal support in the breast.
The critical fact that most Texas patients were never told is that none of these devices have been approved or cleared by the FDA specifically for use in breast surgery. While they may have clearance for general soft-tissue reinforcement or hernia repair, their safety in the unique immunological and hormonal environment of the breast remains unproven by federal standards.
The FDA Regulatory Failure: 510(k) Clearance and “Predicate Creep”
To understand why these devices are in the market, we must look at the FDA’s 21 CFR Part 807 Subpart E, known as the 510(k) clearance pathway. Unlike the rigorous Premarket Approval (PMA) process required for higher-risk Class III devices, the 510(k) pathway allows a manufacturer to market a device by simply showing it is “substantially equivalent” to a previous “predicate” device.
This has led to a phenomenon called “predicate creep.” For example, the manufacturers of GalaFLEX (Galatea Surgical and Becton Dickinson) cited a surgical suture as one of their predicate devices to gain clearance for their mesh. A suture used for a single stitch is not the same as a large scaffold used to support a breast implant, yet the 510(k) system permitted this jump. As the U.S. Supreme Court noted in Medtronic, Inc. v. Lohr, 518 U.S. 470 (1996), 510(k) clearance is a comparative finding of equivalence, not an independent determination that a device is safe and effective for its intended use.
In Texas, we have seen the results of this regulatory shortcut firsthand. The FDA’s March 31, 2021, communication explicitly warned that certain ADM products, specifically FlexHD and AlloMax, were associated with significantly higher rates of reoperation and infection. Despite these warnings, these products remained in use across hospital systems in the Southern District of Texas and throughout the state until further letters to healthcare providers were issued in late 2023.
Verbatim FDA Warnings Affecting Texas Patients
On November 9, 2023, the FDA issued a direct letter to health care providers regarding BD Mesh Products, including GalaFLEX and Phasix. This letter is a vital piece of evidence for any Texas resident considering legal action. The FDA stated:
“The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.”
The agency went on to identify that:
“No surgical mesh products have been cleared or approved by the FDA for use in breast surgery.”
For a reconstruction patient in Austin or a cosmetic patient in Beaumont, this means the device in your body was used “off-label” based on manufacturer marketing, not on FDA-validated safety. If you received one of these devices and are now experiencing complications, Ralph Manginello and the team at Attorney911 are ready to help you hold these manufacturers accountable. Call 1-888-ATTY-911 to discuss your operative reports and your history.
The Complication Spectrum: What Texas Survivors Experience
The range of injuries associated with defective breast mesh and scaffolds is broad and often requires multiple painful revision surgeries. In our twenty-seven years of practice, we have seen how these complications impact the quality of life for women in Texas.
BIA-ALCL: Breast Implant-Associated Anaplastic Large Cell Lymphoma
This is a CD30-positive, ALK-negative T-cell lymphoma that develops in the scar tissue (capsule) around the implant. It has been primarily associated with textured surfaces, such as those found on Allergan BIOCELL implants (which were subject to a July 2019 recall). Patients often present with a late-onset periprosthetic seroma—a collection of fluid occurring seven to ten years after surgery. If you were treated at a major center like MD Anderson in Houston and have developed this condition, your case may be part of the ongoing MDL 2921 litigation.
BIA-SCC: Breast Implant-Associated Squamous Cell Carcinoma
A rarer but equally serious malignancy, BIA-SCC was the subject of a September 2022 FDA Safety Communication. Unlike the lymphoma mentioned above, this is an epithelial tumor of the capsule itself and has been found in patients with both textured and smooth implants.
Red Breast Syndrome (RBS) and Endotoxin Science
Patients in Texas often report a sterile inflammation where the breast skin turns bright red without a fever or clinical infection. This is known as Red Breast Syndrome and is frequently linked to endotoxins (lipopolysaccharides) left on acellular dermal matrices during the manufacturing process. Even “sterile” products like Strattice or FlexHD can retain these inflammatory triggers, causing your body to reject the matrix.
Structural Failures and Reconstruction Loss
We represent women across Texas whose bioabsorbable scaffolds failed to resorb on the advertised eighteen-to-twenty-four-month timeline. Instead of dissolving, the GalaFLEX or Phasix mesh remained palpable, causing chronic pain, mesh extrusion through the skin, or a “bottoming out” of the reconstruction that requires complete explantation and autologous tissue flap salvage (such as a DIEP flap).
Why Generalist Firms Struggle with Device Litigation
Many personal injury firms in Texas handle car accidents or slip-and-falls, but they may not understand the complexities of federal preemption and the “parallel-claim” exception. Under Riegel v. Medtronic, 552 U.S. 312 (2008), the industry often argues that because a device went through some form of FDA review, a patient cannot sue under state law.
However, because most breast mesh products were cleared through the 510(k) pathway, they do not enjoy the same preemptive shield as Class III PMA devices. At The Manginello Law Firm, PLLC, we know how to navigate the “parallel-claim” survivability map. We focus on showing that the manufacturer violated federal requirements—such as those found in 21 CFR Part 803 for Medical Device Reporting—which allows your state-law negligence claim to survive in a Texas federal court.
If you are a student at the University of Houston or a professional in the Austin tech sector, you deserve a firm that understands the science of P4HB hydrolysis and the pathology of T-cell receptor monoclonality. We don’t just “handle” cases; we prosecute them with high-profile capability. Our recent litigation in Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 in damages for an institutional liability case in Harris County, proves that we have the resources to take on massive defendants.
The Whistleblower: Dr. Hooman Noorchashm and GalaFLEX
A critical development for Texas patients involves Dr. Hooman Noorchashm, a cardiothoracic surgeon and former Medical Director for Becton Dickinson (BD). In 2022, Dr. Noorchashm was terminated after raising alarms about the safety of GalaFLEX and Phasix in breast surgery. He alleged that the company withheld data regarding breast cancer recurrences in patients who received these scaffolds and failed to report adverse events to the FDA’s MAUDE database as required by 21 CFR §803.50.
This whistleblower record provides a roadmap for liability. It suggests that manufacturers were aware of the risks but continued to aggressively promote these devices off-label to surgeons in Houston, Dallas, and beyond. This “off-label promotion” creates an exception to the learned intermediary doctrine, which usually protects manufacturers by arguing they only need to warn the doctor. If the manufacturer misled the doctor through biased “education” or withheld data, the responsibility shifts back to the company.
Texas Statute of Limitations and Your Rights
Time is a critical factor for any injured patient in Texas. Generally, you have two years from the date of your injury or the date you discovered the link between your injury and the device to file a lawsuit (Texas Civil Practice and Remedies Code § 16.003).
However, identifying that link can be difficult. You may have had a reconstruction failure in 2020 but only realized the role of the mesh after reading about the 2023 FDA labeling update. This “discovery rule” analysis is complex and requires an experienced attorney. Additionally, Texas has a 15-year statute of repose, meaning that for most products, an action cannot be brought more than fifteen years after the date of sale.
Don’t wait until the clock runs out. Evidence like operative reports, device implant stickers (Unique Device Identifiers/UDI), and pathology slides must be preserved immediately. Our firm assists Texas patients in securing these records before they are purged by hospital systems. Call 1-888-ATTY-911 today.
Bilingual Representation: El Ventaja de Lupe Peña
En Texas, entendemos que muchas pacientes prefieren comunicarse en español sobre temas médicos y legales tan serios. Lupe Eleno Peña, abogado asociado de nuestra firma, nació y se crió en Sugar Land y es un tejano de tercera generación con raíces familiares en el King Ranch. Lupe realiza consultas completas en español sin necesidad de intérpretes. Esto asegura que nada se pierda en la traducción cuando discutimos su cirugía, su dolor y su camino hacia la justicia. Al elegir a Attorney911, usted cuenta con un equipo que no solo conoce la ley de Texas, sino que también habla su idioma.
Leading Manufacturers and Defective Brands
We are currently investigating claims involving the following products used in Texas surgical centers:
- Acellular Dermal Matrices: AlloDerm (AbbVie/Allergan), Strattice, FlexHD (MTF Biologics), AlloMax (C.R. Bard/BD), SurgiMend (Integra LifeSciences).
- Bioabsorbable Scaffolds: GalaFLEX, GalaSHAPE, Phasix (Becton Dickinson/Galatea).
- Synthetic Mesh: Any polypropylene or composite mesh used off-label in the breast envelope.
- Implants Associated with BIA-ALCL: Allergan BIOCELL textured implants and tissue expanders (MDL 2921).
If your operative notes mention any of these brands, or if you were told you received an “internal bra” or “biological mesh,” you may have a claim for damages including medical expenses, pain and suffering, and permanent disfigurement.
Recovery and Results: The Attorney911 Advantage
Ralph Manginello’s twenty-seven years of experience in the U.S. District Court for the Southern District of Texas has earned him an Avvo Rating of 8.2 (Excellent) and a Martindale-Hubbell Preeminent designation. Our firm is not a settlement mill; we are trial attorneys.
When we represented the plaintiff in the University of Houston hazing lawsuit (Bermudez v. Pi Kappa Phi), our aggressive litigation led to the immediate shutdown of the chapter and gained national media attention from KPRC 2, ABC13, and KHOU 11. We bring that same level of institutional pressure to lawsuits against medical device manufacturers. We are members of the Pro Bono College of the State Bar of Texas, reflecting our commitment to service and justice for all Texans.
Frequently Asked Questions for Texas Patients
Is surgical mesh approved for breast reconstruction in Texas?
No. As the FDA stated in late 2023, no surgical mesh product has been cleared or approved specifically for use in breast surgery. Any such use is “off-label,” often driven by manufacturer marketing rather than independent clinical trials.
What if my mesh was “bioabsorbable”?
Even if your scaffold (like GalaFLEX) was designed to dissolve, it can still cause serious harm. Many patients report that the material does not resorb on time, leading to palpable lumps, chronic inflammation, or mesh migration.
How do I find out what was used in my surgery?
You have a legal right to your medical records in Texas. You should request your “Operative Report” and your “Implant Log” from the hospital or surgical center. Look for device stickers or UDI numbers. If you have trouble getting these, our firm can help.
Can I sue if I have “Breast Implant Illness” (BII)?
While BII is often a clinical diagnosis based on systemic symptoms like fatigue and joint pain, we can investigate whether a defective mesh or ADM contributed to your inflammatory response. Many women in the Houston and Austin areas have found that explanting both the implant and the mesh significantly improved their symptoms.
Does it cost anything to start a breast mesh claim?
We operate on a contingency fee basis. This means there is no upfront cost to you, and we only get paid if we recover compensation through a settlement or verdict. We take the financial risk so you can focus on your recovery.
Why Choose The Manginello Law Firm (Attorney911)?
Choosing the right lawyer in Texas can be the difference between a dismissed case and a multi-million-dollar recovery. Ralph Manginello and Lupe Peña offer:
- Federal Court Admission: We are admitted to practice in the Southern District of Texas, where many of these national lawsuits are filed or transferred.
- Insider Knowledge: We understand the defense playbook because our attorneys have backgrounds in insurance defense, allowing us to anticipate their tactics.
- Third-Party Verification: Our firm holds a 4.9 of 5.0 star rating on Birdeye across hundreds of reviews. Ralph has been recognized by the Cheshire Academy Hall of Fame and carries elite peer endorsements from fellow Houston attorneys.
- Local Roots: From our principal office at 1177 West Loop South in Houston to our presence in Austin and Beaumont, we serve Harris, Travis, Montgomery, Fort Bend, Brazoria, and Jefferson counties with local expertise.
Take the Next Step Toward Justice in Texas
If you or a loved one in Texas have suffered from a diagnosis of BIA-ALCL, an infection requiring the removal of your reconstruction, or persistent pain from a bioabsorbable scaffold, you are not alone. The manufacturers of these devices prioritized market share over patient safety, and the “predicate creep” of the 510(k) pathway allowed these products into Texas operating rooms without adequate testing.
Call us today at 1-888-ATTY-911 or visit us online to schedule your free consultation. Whether you are in Houston, Austin, Beaumont, or anywhere else in our great state, we are ready to listen to your story and fight for the compensation you deserve.
The Manginello Law Firm, PLLC (Attorney911)
1177 West Loop South, Suite 1600
Houston, Texas 77027
1-888-ATTY-911 (1-888-288-9911)
https://attorney911.com/
Hablamos español. No fee unless we recover for you. Serving all of Texas since 1998.
